Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vanda Pharmaceuticals

4.51
-0.0200-0.44%
Post-market: 4.510.00000.00%16:11 EDT
Volume:323.68K
Turnover:1.47M
Market Cap:265.79M
PE:-5.92
High:4.60
Open:4.57
Low:4.49
Close:4.53
Loading ...
Feb 16, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 08, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Major Issues Report

Form 8-K - Current report
Dec 07, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 21, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 28, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2023

Major Issues Report

Form 8-K - Current report
Jul 28, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 09, 2023

Major Issues Report

Form 8-K - Current report